Lei Jin
University Hospital Münster · 87 works · 10,140 citations · h-index 40
Top works
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- The anticoagulant activation of antithrombin by heparin
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
- A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
- Crystal structure of calcium bound domain VI of calpain at 1.9 Å resolution and its role in enzyme assembly, regulation, and inhibitor binding
- Bridging the NFAT and NF-κB Families
- Structure of the collagen-binding domain from a Staphylococcus aureus adhesin
- Chemogenetic Analysis of Human Protein Methyltransferases
- Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin
- Crystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes
- Discovery of Thieno[3,2-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3
- The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states
- Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3
- Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine‐based Compounds
- Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma
- An asymmetric NFAT1 dimer on a pseudo-palindromic κB-like DNA site
- Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L